Pancreatic Cancer Research

ResearcherUtrecht UniversityNo recent work listed

Jan H.M. Schellens

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6832-1976; OpenAlex author ID A5000418012. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 4

  1. Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer. Last author DOI 10.1002/onco.13631↗
  2. Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer. Last author DOI 10.1007/s00280-020-04066-4↗
  3. Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung… Last author DOI 10.1038/s41416-020-0776-z↗
  4. Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer. Co-author DOI 10.1007/s00280-015-2730-y↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Emilie M.J. van Brummelen · 3 shared papers, 2020–2021 · strength 0.30
  2. Sanne C.F.A. Huijberts · 3 shared papers, 2020–2021 · strength 0.30
  3. Frans L. Opdam · 3 shared papers, 2020–2021 · strength 0.30
  4. Robin M.J.M. van Geel · 3 shared papers, 2020–2021 · strength 0.30
  5. René Bernards · 3 shared papers, 2020–2021 · strength 0.30
  6. Ferry A.L.M. Eskens · 1 shared paper, 2020 · strength 0.09
  7. Dick J. Richel · 1 shared paper, 2015 · strength 0.06
  8. Johanna W. Wilmink · 1 shared paper, 2015 · strength 0.06
  9. Heinz‐Josef Klümpen · 1 shared paper, 2015 · strength 0.06
  10. Sil Kordes · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.